Christian Capitini, MD, Awarded National Cancer Institute Funding

Christian Capitini, MD
Christian Capitini, MD

Congratulations to Christian Capitini, MD, and Co-Investigator Sean Fain, PhD, who were recently awarded a 5-year grant from the National Institutes of Health-National Cancer Institute (NIH-NCI) for their project entitled, "Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma." This R01 award for over $1.75 million in total costs, will use murine allogeneic hematopoietic stem cell transplant (alloHSCT) models to develop evidence for a clinically applicable combined strategy that utilizes the immunocytokine hu14.18-IL2 to enhance the graft-versus-tumor effect of immunologically activated, ex-vivo activated natural killer (NK) cells, and to track the localization of these NK cells using a novel 19F-MRI platform.